Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases

被引：168

作者：

Catala, A. ^{[1
]}

Munoz-Santos, C. ^{[2
]}

Galvan-Casas, C. ^{[3
]}

Roncero Riesco, M. ^{[4
]}

Revilla Nebreda, D. ^{[4
]}

Sola-Truyols, A. ^{[5
]}

Giavedoni, P. ^{[1
]}

Llamas-Velasco, M. ^{[6
]}

Gonzalez-Cruz, C. ^{[7
]}

Cubiro, X. ^{[8
]}

Ruiz-Villaverde, R. ^{[9
]}

Gomez-Armayones, S. ^{[1
]}

Gil Mateo, M. P. ^{[10
]}

Pesque, D. ^{[11
]}

Marcantonio, O. ^{[11
]}

Fernandez-Nieto, D. ^{[12
]}

Romani, J. ^{[13
]}

Iglesias Pena, N. ^{[14
]}

Carnero Gonzalez, L. ^{[15
]}

Tercedor-Sanchez, J. ^{[16
]}

Carretero, G. ^{[17
]}

Masat-Tico, T. ^{[18
]}

Rodriguez-Jimenez, P. ^{[6
]}

Gimenez-Arnau, A. M. ^{[11
]}

Utrera-Busquets, M. ^{[19
]}

Vargas Laguna, E. ^{[20
]}

Angulo Menendez, A. G. ^{[21
]}

San Juan Lasser, E.

Iglesias-Sancho, M. ^{[22
]}

Alonso Naranjo, L. ^{[23
]}

Hiltun, I ^{[24
]}

Cutillas Marco, E. ^{[25
]}

Polimon Olabarrieta, I ^{[3
]}

Marinero Escobedo, S. ^{[3
]}

Garcia-Navarro, X. ^{[26
]}

Calderon Gutierrez, M. J.

Baeza-Hernandez, G. ^{[27
]}

Bou Camps, L.

Toledo-Pastrana, T. ^{[28
]}

Guilabert, A. ^{[2
]}

机构：

[1] Hosp Clin Barcelona, Serv Dermatol, Barcelona, Spain

[2] Hosp Gen Granollers, Serv Dermatol, Barcelona, Spain

[3] Hosp Univ Mostoles, Serv Dermatol, Madrid, Spain

[4] Complejo Asistencial Univ Salamanca, Serv Dermatol, Salamanca, Spain

[5] Hosp Univ Son Llatzer, Serv Dermatol, Mallorca, Spain

[6] Hosp Univ La Princesa, Serv Dermatol, Madrid, Spain

[7] Hosp Univ Vall DHebron, Serv Dermatol, Barcelona, Spain

[8] Hosp Santa Creu & Sant Pau, Serv Dermatol, Barcelona, Spain

[9] Hosp Univ San Cecilio, Serv Dermatol, Granada, Spain

[10] Hosp Gen La Palma, Serv Dermatol, Santa Cruz De Tenerife, Spain

[11] Univ Autonoma Barcelona, IMIM, Hosp Mar, Serv Dermatol, Barcelona, Spain

[12] Hosp Raman & Cajal, Serv Dermatol, Madrid, Spain

[13] Parc Tauli Hosp Univ, Serv Dermatol, Barcelona, Spain

[14] Hosp Univ Lucus Augusti, Serv Dermatol, Lugo, Spain

[15] Hosp Univ Araba, Serv Dermatol, Vitoria, Spain

[16] Hosp Virgen de las Nieves, Serv Dermatol, Granada, Spain

[17] Hosp Univ Gran Canaria Doctor Negrin, Serv Dermatol, Las Palmas Gran Canaria, Spain

[18] Inst Catala Salut, CAP Cardedeu, Barcelona, Spain

[19] Hosp Comarcal Infanta Elena, Serv Dermatol, Huelva, Spain

[20] Hosp Univ Severo Ochoa, Serv Dermatol, Madrid, Spain

[21] Serv Med Penedes Vilanova & Geltru, Serv Dermatol, Barcelona, Spain

[22] Hosp Univ Sagrat Cor, Serv Dermatol, Madrid, Spain

[23] Hosp Univ Toledo, Serv Dermatol, Toledo, Spain

[24] Complejo Hosp Navarra, Serv Dermatol, Navarra, Spain

[25] Hosp Gen Univ Reina Sofia, Serv Dermatol, Murcia, Spain

[26] Consorci Sanitari Alt Penedes Garraf, Serv Dermatol, Barcelona, Spain

[27] Hosp Univ Fuenlabrada, Serv Dermatol, Madrid, Spain

[28] Hosp Quironsalud Infanta Luisa, Seville, Spain

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 01期

关键词：

COVID-19; VACCINATION;

D O I：

10.1111/bjd.20639

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background Cutaneous reactions after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are poorly characterized. Objective To describe and classify cutaneous reactions after SARS-CoV-2 vaccination. Methods A nationwide Spanish cross-sectional study was conducted. We included patients with cutaneous reactions within 21 days of any dose of the approved vaccines at the time of the study. After a face-to-face visit with a dermatologist, information on cutaneous reactions was collected via an online professional survey and clinical photographs were sent by email. Investigators searched for consensus on clinical patterns and classification. Results From 16 February to 15 May 2021, we collected 405 reactions after vaccination with the BNT162b2 (Pfizer-BioNTech; 40 center dot 2%), mRNA-1273 (Moderna; 36 center dot 3%) and AZD1222 (AstraZeneca; 23 center dot 5%) vaccines. Mean patient age was 50 center dot 7 years and 80 center dot 2% were female. Cutaneous reactions were classified as injection site ('COVID arm', 32 center dot 1%), urticaria (14 center dot 6%), morbilliform (8 center dot 9%), papulovesicular (6 center dot 4%), pityriasis rosea-like (4 center dot 9%) and purpuric (4%) reactions. Varicella zoster and herpes simplex virus reactivations accounted for 13 center dot 8% of reactions. The COVID arm was almost exclusive to women (95 center dot 4%). The most reported reactions in each vaccine group were COVID arm (mRNA-1273, Moderna, 61 center dot 9%), varicella zoster virus reactivation (BNT162b2, Pfizer-BioNTech, 17 center dot 2%) and urticaria (AZD1222, AstraZeneca, 21 center dot 1%). Most reactions to the mRNA-1273 (Moderna) vaccine were described in women (90 center dot 5%). Eighty reactions (21%) were classified as severe/very severe and 81% required treatment. Conclusions Cutaneous reactions after SARS-CoV-2 vaccination are heterogeneous. Most are mild-to-moderate and self-limiting, although severe/very severe reactions are reported. Knowledge of these reactions during mass vaccination may help healthcare professionals and reassure patients.

引用

页码：142 / 152

页数：11

共 50 条

[41] A cross-sectional overview of SARS-CoV-2 genome variations in Turkey
Ergunay, Koray
Kaya, Mucahit
Serdar, Muhittin
Akyon, Yakut
Yilmaz, Engin
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2021, 46 (05): : 491 - 498
[42] New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study
Carrion-Nessi, Fhabian S.
Ascanio, Luis C.
Pineda-Arape, Andreina G.
Omana-Avila, oscar D.
Mendoza-Millan, Daniela L.
Romero, Sinibaldo R.
Almao-Rivero, Abranny B.
Camejo-Avila, Natasha A.
Gebran-Chedid, Karim J.
Rodriguez-Saavedra, Carlis M.
Freitas-De Nobrega, Diana C.
Castaneda, Sergio A.
Forero-Pena, Jose L.
Delgado-Noguera, Lourdes A.
Meneses-Ramirez, Lucianny K.
Cotua, Juan C.
Rodriguez-Morales, Alfonso J.
Forero-Pena, David A.
Paniz-Mondolfi, Alberto E.
BMC INFECTIOUS DISEASES, 2023, 23 (01)
[43] Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers
Eiros, Rocio
Barreiro-Perez, Manuel
Martin-Garcia, Ana
Almeida, Julia
Villacorta, Eduardo
Perez-Pons, Alba
Merchan, Soraya
Torres-Valle, Alba
Sanchez-Pablo, Clara
Gonzalez-Calle, David
Perez-Escurza, Oihane
Toranzo, Ines
Diaz-Pelaez, Elena
Fuentes-Herrero, Blanca
Macias-Alvarez, Laura
Oliva-Ariza, Guillermo
Lecrevisse, Quentin
Fluxa, Rafael
Bravo-Grande, Jose L.
Orfao, Alberto
Sanchez, Pedro L.
REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (09): : 734 - 746
[44] Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection-A Cross-Sectional Study
Jud, Philipp
Gressenberger, Paul
Muster, Viktoria
Avian, Alexander
Meinitzer, Andreas
Strohmaier, Heimo
Sourij, Harald
Raggam, Reinhard B.
Stradner, Martin Helmut
Demel, Ulrike
Kessler, Harald H.
Eller, Kathrin
Brodmann, Marianne
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[45] New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study
Fhabián S. Carrión-Nessi
Luis C. Ascanio
Andreína G. Pineda-Arapé
Óscar D. Omaña-Ávila
Daniela L. Mendoza-Millán
Sinibaldo R. Romero
Abranny B. Almao-Rivero
Natasha A. Camejo-Ávila
Karim J. Gebran-Chedid
Carlis M. Rodriguez-Saavedra
Diana C. Freitas-De Nobrega
Sergio A. Castañeda
José L. Forero-Peña
Lourdes A. Delgado-Noguera
Lucianny K. Meneses-Ramírez
Juan C. Cotuá
Alfonso J. Rodriguez-Morales
David A. Forero-Peña
Alberto E. Paniz-Mondolfi
BMC Infectious Diseases, 23
[46] Association Between Sociodemographic Factors and Vaccine Acceptance for Influenza and SARS-CoV-2 in South Korea: Nationwide Cross-Sectional Study
Hong, Seohyun
Son, Yejun
Lee, Myeongcheol
Lee, Jun Hyuk
Park, Jaeyu
Lee, Hayeon
Dragioti, Elena
Fond, Guillaume
Boyer, Laurent
Lopez Sanchez, Guillermo Felipe
Smith, Lee
Tully, Mark A.
Rahmati, Masoud
Choi, Yong Sung
Lee, Young Joo
Yeo, Seung Geun
Woo, Selin
Yon, Dong Keon
JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10
[47] Seroprevalence study of the new coronavirus (SARS-CoV-2) in families and cohabitants of confirmed cases in Mashhad, Iran: a cross-sectional study
Amir Masoud Hashemian
Nafiseh Todarbari
Manouchehr Teymouri
Vahid Hajali
Seyed Jalal Ghorbani
Ehsan Saburi
VirusDisease, 2025, 36 (1) : 12 - 19
[48] Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
Ljung, Rickard
Pihlstrom, Nicklas
Sundstrom, Anders
BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : 775 - 776
[49] Geographic concentration of SARS-CoV-2 cases by social determinants of health in metropolitan areas in Canada: a cross-sectional study
Xia, Yiqing
Ma, Huiting
Moloney, Gary
Garcia, Hector A. Velasquez
Sirski, Monica
Janjua, Naveed Z.
Vickers, David
Williamson, Tyler
Katz, Alan
Yiu, Kristy
Kustra, Rafal
Buckeridge, David L.
Brisson, Marc
Baral, Stefan D.
Mishra, Sharmistha
Maheu-Giroux, Mathieu
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (06) : E195 - E204
[50] Reactions of physicians in the state of Sao Paulo to the use of telemedicine during the SARS-CoV-2 pandemic: cross-sectional study
Gomes Amaral, Jose Luiz, I
Endrigo, Antonio Carlos
Malik, Ana Maria
Niituma Ogata, Alberto Jose
Assumpcao Neto, Jorge Correa
SAO PAULO MEDICAL JOURNAL, 2022, 140 (03): : 499 - 504

← 1 2 3 4 5 →